|
B4GALT5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.61379999996658E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.76534999999367E-05 |
| Normal-vs-Stage2 |
1.038070E-02 |
| Normal-vs-Stage3 |
3.764700E-04 |
| Normal-vs-Stage4 |
1.166480E-04 |
| Stage1-vs-Stage2 |
4.843600E-01 |
| Stage1-vs-Stage3 |
8.607400E-01 |
| Stage1-vs-Stage4 |
4.189800E-01 |
| Stage2-vs-Stage3 |
5.989400E-01 |
| Stage2-vs-Stage4 |
2.350800E-01 |
| Stage3-vs-Stage4 |
4.006400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.32450000003936E-06 |
| Normal-vs-AfricanAmerican |
1.609970E-02 |
| Normal-vs-Asian |
5.723700E-03 |
| Caucasian-vs-AfricanAmerican |
9.370800E-01 |
| Caucasian-vs-Asian |
3.738400E-01 |
| AfricanAmerican-vs-Asian |
4.707400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.956700E-04 |
| Normal-vs-Female |
1.14070000112321E-08 |
| Male-vs-Female |
6.034300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.342400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.76679999999807E-06 |
| Normal-vs-Age(61-80Yrs) |
3.86669999999922E-05 |
| Normal-vs-Age(81-100Yrs) |
2.018200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.318000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.272400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.968200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.160200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.036800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.106600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.389780E-02 |
| Normal-vs-Grade 2 |
2.17259999999442E-05 |
| Normal-vs-Grade 3 |
4.20520000000701E-05 |
| Normal-vs-Grade 4 |
4.778800E-04 |
| Grade 1-vs-Grade 2 |
8.250200E-01 |
| Grade 1-vs-Grade 3 |
8.515000E-01 |
| Grade 1-vs-Grade 4 |
9.887600E-01 |
| Grade 2-vs-Grade 3 |
8.163600E-01 |
| Grade 2-vs-Grade 4 |
6.436000E-01 |
| Grade 3-vs-Grade 4 |
8.090200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.78250000004709E-06 |
| Normal-vs-ccB subtype |
5.72009999999512E-05 |
| ccA subtype-vs-ccB subtype |
9.717600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.24400000001135E-06 |
| Normal-vs-N1 |
1.532480E-02 |
| N0-vs-N1 |
1.044620E-01 |
|
|
